282 related articles for article (PubMed ID: 2030821)
1. The gamma-hydroxybutyrate model of absence seizures: correlation of regional brain levels of gamma-hydroxybutyric acid and gamma-butyrolactone with spike wave discharges.
Snead OC
Neuropharmacology; 1991 Feb; 30(2):161-7. PubMed ID: 2030821
[TBL] [Abstract][Full Text] [Related]
2. Experimental absence seizures: potential role of gamma-hydroxybutyric acid and GABAB receptors.
Bernasconi R; Lauber J; Marescaux C; Vergnes M; Martin P; Rubio V; Leonhardt T; Reymann N; Bittiger H
J Neural Transm Suppl; 1992; 35():155-77. PubMed ID: 1324978
[TBL] [Abstract][Full Text] [Related]
3. gamma-Hydroxybutyric acid-induced seizures bear no relation to core temperature.
Snead OC
Epilepsia; 1990; 31(3):253-8. PubMed ID: 2344842
[TBL] [Abstract][Full Text] [Related]
4. GABAA receptor function in the gamma-hydroxybutyrate model of generalized absence seizures.
Snead OC; Liu CC
Neuropharmacology; 1993 Apr; 32(4):401-9. PubMed ID: 8388552
[TBL] [Abstract][Full Text] [Related]
5. Effects of gamma-hydroxybutyrate and gamma-butyrolactone derivates on spontaneous generalized non-convulsive seizures in the rat.
Depaulis A; Bourguignon JJ; Marescaux C; Vergnes M; Schmitt M; Micheletti G; Warter JM
Neuropharmacology; 1988 Jul; 27(7):683-9. PubMed ID: 3419549
[TBL] [Abstract][Full Text] [Related]
6. gamma-Butyrolactone-induced absence-like seizures increase nuclear CRE- and AP-1 DNA-binding activities in mouse brain.
Ishige K; Aizawa M; Ito Y; Fukuda H
Neuropharmacology; 1996 Jan; 35(1):45-55. PubMed ID: 8684596
[TBL] [Abstract][Full Text] [Related]
7. gamma-Hydroxybutyrate model of generalized absence seizures: further characterization and comparison with other absence models.
Snead OC
Epilepsia; 1988; 29(4):361-8. PubMed ID: 3391142
[TBL] [Abstract][Full Text] [Related]
8. Ontogeny of gamma-hydroxybutyric acid. II. Electroencephalographic effects.
Snead OC
Brain Res; 1984 Jul; 317(1):89-96. PubMed ID: 6432219
[TBL] [Abstract][Full Text] [Related]
9. Gamma butyrolactone (GBL) and gamma valerolactone (GVL): similarities and differences in their effects on the acoustic startle reflex and the conditioned enhancement of startle in the rat.
Marinetti LJ; Leavell BJ; Jones CM; Hepler BR; Isenschmid DS; Commissaris RL
Pharmacol Biochem Behav; 2012 Jun; 101(4):602-8. PubMed ID: 22349589
[TBL] [Abstract][Full Text] [Related]
10. The ontogeny of GABAergic enhancement of the gamma-hydroxybutyrate model of generalized absence seizures.
Snead OC
Epilepsia; 1990; 31(4):363-8. PubMed ID: 2369873
[TBL] [Abstract][Full Text] [Related]
11. Involvement of excitatory amino acid mechanisms in gamma-hydroxybutyrate model of generalized absence seizures in rats.
Banerjee PK; Snead OC
Neuropharmacology; 1992 Oct; 31(10):1009-19. PubMed ID: 1436382
[TBL] [Abstract][Full Text] [Related]
12. Behavioral effects and pharmacokinetics of gamma-hydroxybutyrate (GHB) precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) in baboons.
Goodwin AK; Brown PR; Jansen EE; Jakobs C; Gibson KM; Weerts EM
Psychopharmacology (Berl); 2009 Jun; 204(3):465-76. PubMed ID: 19198808
[TBL] [Abstract][Full Text] [Related]
13. Gamma-Hydroxybutyrate (GHB), gamma-butyrolactone (GBL), and 1,4-butanediol (1,4-BD) reduce the volume of cerebral infarction in rodent transient middle cerebral artery occlusion.
Sadasivan S; Maher TJ; Quang LS
Ann N Y Acad Sci; 2006 Aug; 1074():537-44. PubMed ID: 17105951
[TBL] [Abstract][Full Text] [Related]
14. Impact of strain, sex, and estrous cycle on gamma butyrolactone-evoked absence seizures in rats.
Santos VR; Kobayashi I; Hammack R; Danko G; Forcelli PA
Epilepsy Res; 2018 Nov; 147():62-70. PubMed ID: 30261353
[TBL] [Abstract][Full Text] [Related]
15. Tolerance to the hypnotic and electroencephalographic effect of gamma-hydroxybutyrate in the rat: pharmacokinetic and pharmacodynamic aspects.
Van Sassenbroeck DK; De Paepe P; Belpaire FM; Boon PA; Buylaert WA
J Pharm Pharmacol; 2003 May; 55(5):609-15. PubMed ID: 12831503
[TBL] [Abstract][Full Text] [Related]
16. Noradrenergic mechanisms in gamma-hydroxybutyrate-induced seizure activity.
Snead OC
Eur J Pharmacol; 1987 Apr; 136(1):103-8. PubMed ID: 3109925
[TBL] [Abstract][Full Text] [Related]
17. Analysis of biofluids for gamma-hydroxybutyrate (GHB) and gamma-butyrolactone (GBL) by headspace GC-FID and GC-MS.
LeBeau MA; Montgomery MA; Miller ML; Burmeister SG
J Anal Toxicol; 2000 Sep; 24(6):421-8. PubMed ID: 10999347
[TBL] [Abstract][Full Text] [Related]
18. Lack of effects of GHB precursors GBL and 1,4-BD following i.c.v. administration in rats.
Carter LP; Koek W; France CP
Eur J Neurosci; 2006 Nov; 24(9):2595-600. PubMed ID: 17100847
[TBL] [Abstract][Full Text] [Related]
19. Regional Fos-expression induced by γ-hydroxybutyrate (GHB): comparison with γ-butyrolactone (GBL) and effects of co-administration of the GABAB antagonist SCH 50911 and putative GHB antagonist NCS-382.
van Nieuwenhuijzen PS; McGregor IS; Chebib M; Hunt GE
Neuroscience; 2014 Sep; 277():700-15. PubMed ID: 25088910
[TBL] [Abstract][Full Text] [Related]
20. Intrathalamic injections of gamma-hydroxybutyric acid increase genetic absence seizures in rats.
Liu Z; Snead OC; Vergnes M; Depaulis A; Marescaux C
Neurosci Lett; 1991 Apr; 125(1):19-21. PubMed ID: 1857553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
